Inhaltsseite: Home

Yield Enhancement

Yield Enhancement Products in Spotlight

Monday, 23 October 2023 Reading time : 1 minute

The Swiss stock market heavyweights Nestlé, Novartis and Roche together account for half of the weightings of the Swiss Market Index. The relative stability of these stocks makes them popular underlyings for defensive yield enhancement products.

In combination with other stocks from the leading index, attractive returns can be generated despite the tendency towards low volatility. 

Type Valor Underlyings Coupon p.a. Barrier Duration (m) Currency Subsciption until
RC 127347056 Nestlé, Novartis, Roche 7% 90% Strike 12 CHF 27.10.2023
CBRC 127347026 Nestlé, Novartis, Roche 5% 61% 18 CHF 01.11.2023
CBRC 127347028 Nestlé, Novartis, Roche, UBS, Zurich 8% 59% 12 CHF 01.11.2023
Other Products with SMI® Underlyings
CBRC 127347041 UBS, Lonza, Richemont, Sika, Logitech 10% 50% 12 CHF 27.10.2023
BRC 127347042 Julius Bär, Swatch, Givaudan 8% 60% 12 CHF 27.10.2023
BRC 127347043 Alcon, Swisscom, Holcim 8% 65% 12 CHF 27.10.2023
BRC 127347044 Alcon, Straumann, Sonova 8% 63% 12 CHF 27.10.2023
CBRC 127347048 Geberit, Givaudan, ABB 7% 65% 12 CHF 27.10.2023
CBRC 127347051 Lonza, Julius Bär, Swiss Life 10% 63% 12 CHF 27.10.2023
BRC 127347052 Zurich, Swiss Life, Swiss Re 7% 65% 12 CHF 27.10.2023
BRC 127347053 SGS, Kühne + Nagel, Adecco 8% 62% 12 CHF 27.10.2023
BRC 127347054 Logitech 8% 70% 12 CHF 27.10.2023
BRC 127347055 Julius Bär 7% 70% 12 CHF 27.10.2023
BRC 127347060 UBS, Julius Bär, Vontobel 9% 59% 18 CHF 27.10.2023
RC 127347057 Richemont 8% 0% 6 CHF 27.10.2023
BRC 127347027 Zurich, Swiss Life, Swiss Re 6% 59% 18 CHF 01.11.2023



 indicative data
 

Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen. 


Ajax loading